WV HB 4075
died on adjournmentInsurance must cover Bioidentical hormones as they do pharmaceutical one
West Virginia · 2026 Regular Session · lower
Subscribe in a feed reader. The feed covers recorded actions from the last 30 days; Bill Commons may record an action after it happened at the legislature.
Quick answers
Did WV HB 4075 pass?
No. WV HB 4075 died when the 2026 Regular Session adjourned without final action on it. Bills that die this way are sometimes reintroduced in a later session. Latest recorded action (2026-01-14): To House Finance
What is WV HB 4075 about?
WV HB 4075 is a bill in the 2026 Regular Session titled “Insurance must cover Bioidentical hormones as they do pharmaceutical one”.
Who sponsors WV HB 4075?
Crouse is the primary sponsor of WV HB 4075, joined by 2 cosponsors.
- Introduced
- 2026-01-14
- Latest action
- 2026-01-14 — To House Finance
- Bill type
- bill
- Last updated
- —
Subjects
Sponsors
- Crouseprimary
- Howell, T.cosponsor
- Whitecosponsor
Committees
Not provided by source.
Action timeline
Newest first
2026-01-14
To House Finance
referral-committee
2026-01-14
Introduced in House
introduction
2026-01-14
To Finance then Judiciary
referral-committee
2026-01-14
Filed for introduction
filing
Versions
- Introduced VersionCompare
Documents
Votes
Not provided by source.
Related bills
No related bills recorded for this bill.
Official source
Attribution
Data from openstates_bulk_csv, retrieved 2026-07-24T05:38:23.680216Z
Inspect retained evidence for changes recorded after evidence tracking began:
Session-wide evidence can include changes to other bills:
Use this data
Every field on this page is available from the free public API — no key or licence required. Fetch this bill as JSON: GET /api/v1/bills?jurisdiction=WV&identifier=HB 4075. See the API docs or the MCP server for AI assistants.
Known limitations
- Sponsor party and chamber affiliation are not yet captured by this API.
- Committee referrals are not yet captured.
See the methodology page for data sources and limitations.